ISRCTN76193287
Active, not recruiting
Phase 4
A Study of Cardiovascular Events iN Diabetes Plus (ASCEND PLUS)
Overview
- Phase
- Phase 4
- Intervention
- Not specified
- Conditions
- Not specified
- Sponsor
- niversity of Oxford
- Enrollment
- 20000
- Status
- Active, not recruiting
- Last Updated
- 3 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •1\. Adults aged at least 55 years
- •2\. Type 2 diabetes mellitus
Exclusion Criteria
- •1\. Myocardial Infarction
- •3\. Current or planned treatment with a GLP\-1 RA
- •4\. Previous hypersensitivity to or intolerance of GLP\-1 RA therapy
- •5\. Severe hypoglycaemia within the last six months or during run\-in
- •6\. Symptomatic hypoglycaemia within the last month
- •7\. Currently under consideration to commence insulin
- •8\. Severe heart failure (NYHA class 4\)
- •9\. Current or planned renal replacement therapy
- •10\. Unwilling to complete regular follow\-up assessments
- •11\. Ongoing treatment for cancer or diagnosis with cancer (excluding non\-melanoma skin cancer) in the last 2 years
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
Study on complications of diabetes and risk of heart attackCTRI/2019/01/017120Osmania Medical College
Active, not recruiting
Not Applicable
Diabetes and vascular complications: the role of endothelin and physical inactivity’EUCTR2009-015602-18-NLActelion Pharmaceuticals
Completed
Not Applicable
*Diabetes and vascular complications: normoxia versus hypoxia*diabetes mellitus type 210018424NL-OMON35263niversitair Medisch Centrum Sint Radboud20
Not yet recruiting
Not Applicable
Occurrence of heart related risk factors in Diabetes mellitusHealth Condition 1: E115- Type 2 diabetes mellitus with circulatory complicationsCTRI/2020/03/023738Department Of Physiotherapy
Completed
Not Applicable
Microvascular complications of diabetes mellitusmicrovascular complications in patients with diabetes type 1 and 2E14.3DRKS00007880niversitätsklinikum Heidelberg, Klinik für Endokrinologie, Stoffwechsel und Klinische Chemie502